{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:19:57Z","timestamp":1787836797442,"version":"build-2784847793"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP.02-230-43"],"award-info":[{"award-number":["RGP.02-230-43"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109074","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T19:27:49Z","timestamp":1658431669000},"page":"109074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The emerging role of 27-hydroxycholesterol in cancer development and progression: An update"],"prefix":"10.1016","volume":"110","author":[{"given":"Saade","family":"Abdalkareem Jasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzah H.","family":"Kzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Haider Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaed E.","family":"Al-Gazally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukhrat","family":"Ziyadullaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abed Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Thaeer Hammid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khulood H.","family":"Oudaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Karampoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI0216381","article-title":"Cholesterol in health and disease","volume":"110","author":"Tabas","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. metabolism"},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.molmed.2011.05.010","article-title":"Bile acids and colon cancer: Solving the puzzle with nuclear receptors","volume":"17","author":"Degirolamo","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccr.2009.11.006","article-title":"Steroid hormone receptors in prostate cancer: a hard habit to break?","volume":"16","author":"Attard","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10911-015-9340-5","article-title":"Steroid hormones, steroid receptors, and breast cancer stem cells","volume":"20","author":"Finlay-Schultz","year":"2015","journal-title":"J. mammary gland biol. neoplasia"},{"issue":"5285","key":"10.1016\/j.intimp.2022.109074_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.274.5285.255","article-title":"Cholesterol modification of hedgehog signaling proteins in animal development","volume":"274","author":"Porter","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.109074_b0035","doi-asserted-by":"crossref","unstructured":"X. Xiao, J.-J. Tang, C. Peng, Y. Wang, L. Fu, Z.-P. Qiu, Y. Xiong, L.-F. Yang, H.-W. Cui, X.-L. He, Cholesterol modification of smoothened is required for hedgehog signaling, Molecular cell 66(1) (2017) 154-162. e10.","DOI":"10.1016\/j.molcel.2017.02.015"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5393","article-title":"Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling","volume":"5","author":"Sheng","year":"2014","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.intimp.2022.109074_b0045","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1128\/MCB.00941-09","article-title":"Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain","volume":"29","author":"Oneyama","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2022.109074_b0050","doi-asserted-by":"crossref","unstructured":"P. Avena, I. Casaburi, L. Zavaglia, M.C. Nocito, D. La Padula, V. Rago, J. Dong, P. Thomas, C. Mineo, R. Sirianni, P.W. Shaul, 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer, Cancers (Basel) 14(6) (2022) 1521.","DOI":"10.3390\/cancers14061521"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.1995.1110","article-title":"Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry","volume":"225","author":"Dzeletovic","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2022.109074_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2015.11.015","article-title":"Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry","volume":"1439","author":"Pataj","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.intimp.2022.109074_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mam.2016.04.003","article-title":"Oxysterols: an emerging class of broad spectrum antiviral effectors","volume":"49","author":"Lembo","year":"2016","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.taap.2013.12.007","article-title":"27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes","volume":"274","author":"Kim","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2013.07.046","article-title":"Oxysterols induce transition of monocytic cells to phenotypically mature dendritic cell-like cells","volume":"438","author":"Son","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109074_b0080","doi-asserted-by":"crossref","unstructured":"A. Chimento, I. Casaburi, P. Avena, F. Trotta, A. De Luca, V. Rago, V. Pezzi, R. Sirianni, Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment, Frontiers in endocrinology (2019) 807.","DOI":"10.3389\/fendo.2018.00807"},{"issue":"14","key":"10.1016\/j.intimp.2022.109074_b0085","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.3390\/ijms21144822","article-title":"Obesity and cancer: 27-hydroxycholesterol, the missing link","volume":"21","author":"Asghari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109074_b0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.maturitas.2017.07.014","article-title":"27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator","volume":"104","author":"He","year":"2017","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0095","first-page":"637","article-title":"27-Hydroxycholesterol promotes cell-autonomous","volume":"5","author":"Wu","year":"2013","journal-title":"ER-positive breast cancer growth, Cell reports"},{"issue":"6162","key":"10.1016\/j.intimp.2022.109074_b0100","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0105","first-page":"2194","article-title":"Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer","volume":"9","author":"Shi","year":"2019","journal-title":"Am. J. cancer res."},{"key":"10.1016\/j.intimp.2022.109074_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.etap.2017.02.001","article-title":"27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3","volume":"51","author":"Shen","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109074_b0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ctrv.2018.08.004","article-title":"Challenges and perspectives in the treatment of diabetes associated breast cancer","volume":"70","author":"Samuel","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tem.2014.10.001","article-title":"Cholesterol and breast cancer pathophysiology","volume":"25","author":"Nelson","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.intimp.2022.109074_b0125","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1158\/0008-5472.CAN-14-1756","article-title":"Obesity, cholesterol metabolism, and breast cancer pathogenesis","volume":"74","author":"McDonnell","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2022.109074_b0130","article-title":"Our evolving understanding of how 27-hydroxycholesterol influences cancer","volume":"114621","author":"Ma","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"7068","key":"10.1016\/j.intimp.2022.109074_b0135","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2022.109074_b0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fendo.2018.00509","article-title":"Sterol metabolism and transport in atherosclerosis and cancer","volume":"9","author":"Yamauchi","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0145","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1194\/jlr.TR119000439","article-title":"Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy: thematic review series: biology of lipid rafts","volume":"61","author":"Mollinedo","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2022.109074_b0150","doi-asserted-by":"crossref","unstructured":"Y. Wei, Y. Huang, W. Yang, Q. Huang, Y. Chen, K. Zeng, J. Chen, J. Chen, The significances and clinical implications of cholesterol components in human breast cancer, Science Progress 104(3) (2021) 00368504211028395.","DOI":"10.1177\/00368504211028395"},{"issue":"8","key":"10.1016\/j.intimp.2022.109074_b0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.115.016163","volume":"132","author":"Elshazly","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2022.109074_b0160","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.bjc.6602539","article-title":"Serum cholesterol and testicular cancer incidence in 45 000 men followed for 25 years","volume":"92","author":"Wir\u00e9hn","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-6654-9","article-title":"Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study","volume":"94","author":"Bahl","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0170","first-page":"1055","article-title":"Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women","volume":"20","author":"Ha","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S000711451500183X","article-title":"Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies","volume":"114","author":"Touvier","year":"2015","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medici.2016.03.002","article-title":"Hypertension, serum lipids and cancer risk: a review of epidemiological evidence","volume":"52","author":"Radi\u0161auskas","year":"2016","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/hsz-2014-0194","article-title":"Cholesterol lowering: role in cancer prevention and treatment","volume":"396","author":"Murai","year":"2015","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0190","first-page":"219","article-title":"The role of cholesterol metabolism in cancer","volume":"9","author":"Ding","year":"2019","journal-title":"Am. J. cancer res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0195","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am. J. pathol."},{"key":"10.1016\/j.intimp.2022.109074_b0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2016.02.017","article-title":"Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome","volume":"105","author":"Du","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0205","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1074\/jbc.R114.617936","article-title":"Smoothened goes molecular: new pieces in the hedgehog signaling puzzle","volume":"290","author":"McCabe","year":"2015","journal-title":"J. biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.coph.2012.07.002","article-title":"Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer","volume":"12","author":"Riobo","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0215","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cell.2016.08.003","article-title":"Cellular cholesterol directly activates smoothened in hedgehog signaling","volume":"166","author":"Huang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2022.109074_b0220","volume":"5","author":"Luchetti","year":"2016","journal-title":"Cholesterol activates the G-protein coupled receptor Smoothened to promote Hedgehog signaling"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrm1622","article-title":"Communicating with Hedgehogs","volume":"6","author":"Hooper","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2022.109074_b0230","first-page":"14505","volume":"8","author":"Guix\u00e0-Gonz\u00e1lez","year":"2017","journal-title":"Membrane cholesterol access into a G-protein-coupled receptor"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2011.01.003","article-title":"27-Hydroxycholesterol: the first identified endogenous SERM","volume":"22","author":"Umetani","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0240","first-page":"278","article-title":"Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques, Biochimica et Biophysica Acta (BBA)-Lipids and Lipid","volume":"1344","author":"Crisby","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2022.109074_b0245","doi-asserted-by":"crossref","first-page":"d176","DOI":"10.2741\/A273","article-title":"Regulation of bile acid synthesis","volume":"3","author":"Chiang","year":"1998","journal-title":"Frontiers in biosci. a j. virtual library"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"Pt 3","key":"10.1016\/j.intimp.2022.109074_b0255","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1042\/BJ20041776","article-title":"Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands","volume":"385","author":"Quinn","year":"2005","journal-title":"Biochem. J."},{"issue":"18","key":"10.1016\/j.intimp.2022.109074_b0260","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1073\/pnas.91.18.8592","article-title":"Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages","volume":"91","author":"Bj\u00f6rkhem","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0265","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","article-title":"Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis","volume":"266","author":"Cali","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2022.109074_b0270","unstructured":"V, Leoni, On the possible use of oxysterols for the diagnosis and evaluation of patients with neurological and neurodegenerative diseases, Institutionen f\u00f6r laboratoriemedicin\/Department of Laboratory Medicine2005."},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0275","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(98)00196-8","article-title":"Oxysterols and atherosclerosis","volume":"142","author":"Brown","year":"1999","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2006.09.026","article-title":"Lipoprotein distribution and biological variation of 24S-and 27-hydroxycholesterol in healthy volunteers","volume":"194","author":"Burkard","year":"2007","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1872-034X.2008.00450.x","article-title":"Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level","volume":"39","author":"Hirayama","year":"2009","journal-title":"Hepatologyres. the official j. Japan Soc. Hepatol."},{"issue":"24","key":"10.1016\/j.intimp.2022.109074_b0295","doi-asserted-by":"crossref","first-page":"16625","DOI":"10.1074\/jbc.M602723200","article-title":"Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity","volume":"281","author":"Yamamoto","year":"2006","journal-title":"J. biol. Chem."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2022.109074_b0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1388-1981(00)00142-6","article-title":"Oxysterol biosynthetic enzymes","volume":"1529","author":"Russell","year":"2000","journal-title":"Biochimica et biophysica acta"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2010.02.140","article-title":"Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge","volume":"396","author":"Bj\u00f6rkhem","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0310","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1194\/jlr.M002543","article-title":"Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis","volume":"51","author":"Sch\u00fcle","year":"2010","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0315","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.freeradbiomed.2007.12.026","article-title":"Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample","volume":"44","author":"Lee","year":"2008","journal-title":"Free Radical Biol. Med."},{"issue":"22","key":"10.1016\/j.intimp.2022.109074_b0320","doi-asserted-by":"crossref","first-page":"16536","DOI":"10.1074\/jbc.M001811200","article-title":"Disruption of the oxysterol 7alpha-hydroxylase gene in mice","volume":"275","author":"Li-Hawkins","year":"2000","journal-title":"J. biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0325","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0022-2275(20)32094-0","article-title":"Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1","volume":"40","author":"Wu","year":"1999","journal-title":"J Lipid Res"},{"issue":"6602","key":"10.1016\/j.intimp.2022.109074_b0330","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0335","first-page":"985","article-title":"Liver X receptor signaling pathways in cardiovascular disease, Molecular endocrinology (Baltimore","volume":"17","author":"Tontonoz","year":"2003","journal-title":"Md.)"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.109074_b0345","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.109.191197","article-title":"Liver x receptor signaling pathways and atherosclerosis","volume":"30","author":"Calkin","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109074_b0350","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.intimp.2022.109074_b0355","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.CIR.0000026802.79202.96","article-title":"Accumulation of foam cells in liver X receptor-deficient mice","volume":"106","author":"Schuster","year":"2002","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.intimp.2022.109074_b0360","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Sasso","year":"2010","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2006.11.012","article-title":"Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice","volume":"5","author":"Chen","year":"2007","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0375","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.0000013312.32196.49","article-title":"Oxysterols: friends, foes, or just fellow passengers?","volume":"22","author":"Bj\u00f6rkhem","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2796.2011.02389.x","article-title":"Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo","volume":"270","author":"Shafaati","year":"2011","journal-title":"J. Intern. Med."},{"issue":"42","key":"10.1016\/j.intimp.2022.109074_b0385","doi-asserted-by":"crossref","first-page":"38378","DOI":"10.1074\/jbc.M105805200","article-title":"27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells","volume":"276","author":"Fu","year":"2001","journal-title":"J. biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0390","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2014.05.013","article-title":"The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha","volume":"20","author":"Umetani","year":"2014","journal-title":"Cell Metab."},{"issue":"42","key":"10.1016\/j.intimp.2022.109074_b0395","doi-asserted-by":"crossref","first-page":"28485","DOI":"10.1074\/jbc.R109.042168","article-title":"CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions","volume":"284","author":"Stiles","year":"2009","journal-title":"J. biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2006.09.026","article-title":"Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers","volume":"194","author":"Burkard","year":"2007","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0405","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","article-title":"27-hydroxycholesterol: production rates in normal human subjects","volume":"40","author":"Duane","year":"1999","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0005-2760(96)00152-X","article-title":"Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques","volume":"1344","author":"Crisby","year":"1997","journal-title":"Biochimica et biophysica acta"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0415","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0002-9440(10)64890-0","article-title":"Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis","volume":"160","author":"Upston","year":"2002","journal-title":"Am. J. pathol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0420","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00041433-200206000-00003","article-title":"Oxysterols in human circulation: which role do they have?","volume":"13","author":"Bj\u00f6rkhem","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0425","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10715760100300431","article-title":"Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins","volume":"34","author":"Vaya","year":"2001","journal-title":"Free Radical Res."},{"key":"10.1016\/j.intimp.2022.109074_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.691019","article-title":"Miconazole Suppresses 27-Hydroxycholesterol-induced inflammation by regulating activation of monocytic cells to a proinflammatory phenotype","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0435","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1043-2760(00)00255-1","article-title":"Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans","volume":"11","author":"Bj\u00f6rkhem","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2022.109074_b0440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuro.2017.02.001","article-title":"27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells","volume":"59","author":"An","year":"2017","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0445","first-page":"111","article-title":"27-Hydroxycholesterol induces macrophage gene expression via LXR-dependent and-independent mechanisms, The Korean journal of physiology & pharmacology: official journal of the korean physiological society and the korean society of","volume":"25","author":"Kim","year":"2021","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/me.2007-0383","article-title":"27-hydroxycholesterol is an endogenous selective estrogen receptor modulator","volume":"22","author":"DuSell","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0455","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1210\/en.2019-00349","article-title":"27-hydroxycholesterol promotes adiposity and mimics adipogenic diet-induced inflammatory signaling","volume":"160","author":"Asghari","year":"2019","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0460","first-page":"2177","article-title":"4'-O-Methylalpinumisoflavone inhibits the activation of monocytes\/macrophages to an immunostimulatory phenotype induced by 27-hydroxycholesterol","volume":"43","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0465","first-page":"475","article-title":"FSL-1, a Toll-like Receptor 2\/6 agonist, induces expression of interleukin-1\u03b1 in the presence of 27-hydroxycholesterol, the korean journal of physiology & pharmacology : official journal of the korean physiological society and the korean society of","volume":"18","author":"Heo","year":"2014","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0470","first-page":"442","article-title":"27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide","volume":"1852","author":"Kim","year":"2015","journal-title":"BBA"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0475","first-page":"2335","article-title":"Prednisolone suppresses the immunostimulatory effects of 27-hydroxycholesterol","volume":"19","author":"Kim","year":"2020","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0480","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10565-005-0141-2","article-title":"Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols","volume":"21","author":"Lemaire-Ewing","year":"2005","journal-title":"Cell Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mam.2009.02.006","article-title":"Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and\/or oncosis), oxidative and inflammatory activities, and phospholipidosis","volume":"30","author":"Vejux","year":"2009","journal-title":"Mol. Aspects Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-022-00435-2","article-title":"Immunometabolism in biofilm infection: lessons from cancer","volume":"28","author":"Mirzaei","year":"2022","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0495","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bbrc.2016.08.145","article-title":"Diclofenac inhibits 27-hydroxycholesterol-induced inflammation","volume":"478","author":"Kim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109074_b0500","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2020.08.020","article-title":"27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression","volume":"493","author":"Ma","year":"2020","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0505","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tips.2008.07.003","article-title":"27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling","volume":"29","author":"DuSell","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2022.109074_b0510","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jsbmb.2016.06.010","article-title":"Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: results of the OXYTAM study","volume":"169","author":"Dalenc","year":"2017","journal-title":"J. steroid biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0515","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djy115","article-title":"Circulating 27-hydroxycholesterol and breast cancer risk: results from the EPIC-heidelberg cohort","volume":"111","author":"Lu","year":"2019","journal-title":"J. Natl Cancer Inst."},{"issue":"13","key":"10.1016\/j.intimp.2022.109074_b0520","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.intimp.2022.109074_b0525","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","article-title":"Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy","volume":"22","author":"Sverrisdottir","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2022.109074_b0530","doi-asserted-by":"crossref","unstructured":"F. Grodstein, T.B. Clarkson, J.E. Manson, Understanding the divergent data on postmenopausal hormone therapy, New England Journal of Medicine 348(7) (2003) 645-645.","DOI":"10.1056\/NEJMsb022365"},{"key":"10.1016\/j.intimp.2022.109074_b0535","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsbmb.2015.11.002","article-title":"Re-adopting classical nuclear receptors by cholesterol metabolites","volume":"157","author":"Umetani","year":"2016","journal-title":"J. steroid biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0540","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/ERC-16-0533","article-title":"Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer","volume":"24","author":"Kimbung","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-020-00581-2","article-title":"The crosstalk: exosomes and lipid metabolism","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun. Signaling"},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0550","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.R084210","article-title":"Cholesterol and the journey of extracellular vesicles","volume":"59","author":"Pfrieger","year":"2018","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0555","first-page":"185","article-title":"Exosomes in cholesterol metabolism and atherosclerosis, cardiovascular & haematological disorders-drug targets (formerly current drug targets-cardiovascular &","volume":"17","author":"Reiss","year":"2017","journal-title":"Hematol. Disorders)"},{"issue":"34","key":"10.1016\/j.intimp.2022.109074_b0560","doi-asserted-by":"crossref","first-page":"26279","DOI":"10.1074\/jbc.M110.134775","article-title":"Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease","volume":"285","author":"Strauss","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52765-7","article-title":"Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions","volume":"9","author":"Kulshreshtha","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.109074_b0570","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsbmb.2016.02.006","article-title":"Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes","volume":"169","author":"Roberg-Larsen","year":"2017","journal-title":"J. steroid biochem. and mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0575","doi-asserted-by":"crossref","first-page":"bqab095","DOI":"10.1210\/endocr\/bqab095","article-title":"The cholesterol metabolite 27HC increases secretion of extracellular vesicles which promote breast cancer progression","volume":"162","author":"Baek","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2022.109074_b0580","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tiv.2017.07.013","article-title":"The ROS-mediated activation of IL-6\/STAT3 signaling pathway is involved in the 27-hydroxycholesterol-induced cellular senescence in nerve cells","volume":"45","author":"Liu","year":"2017","journal-title":"Toxicol. In Vitro"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2022.109074_b0585","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/10715762.2020.1715965","article-title":"Activation of STAT-3 signalling by RECK downregulation via ROS is involved in the 27-hydroxycholesterol-induced invasion in breast cancer cells","volume":"54","author":"Shen","year":"2020","journal-title":"Free Rad. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01347-x","article-title":"CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients","volume":"22","author":"Kimbung","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0600","first-page":"1","article-title":"Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1","volume":"22","author":"Le Cornet","year":"2020","journal-title":"LXR-\u03b2, and ER\u03b2: results from the EPIC-Heidelberg cohort, Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0605","article-title":"The Level of 27-hydroxycholesterol and Oxysterol 7\u03b1-hydroxylase (CYP7B1) in Tissues of Women with Breast Tumors, Iraqi","volume":"16","author":"Mohammed","year":"2018","journal-title":"J. Med. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0610","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/0008-5472.CAN-16-2738","article-title":"CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer","volume":"77","author":"Alfaqih","year":"2017","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0615","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.23715","article-title":"Association between plasma cholesterol and prostate cancer in the PSA era","volume":"123","author":"Platz","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0620","first-page":"1259","article-title":"Hypercholesterolemia and prostate cancer: a hospital-based case\u2013control study","volume":"19","author":"Magura","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.intimp.2022.109074_b0625","first-page":"1545","article-title":"Serum total and HDL cholesterol and risk of prostate cancer","volume":"22","author":"Mondul","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.intimp.2022.109074_b0630","first-page":"279","article-title":"Prostatic cholesterol metabolism: regulation and alteration","volume":"75","author":"Schaffner","year":"1981","journal-title":"Prog. Clin. Biol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0635","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.1700130103","article-title":"On the occurrence of crystals in tumours","volume":"13","author":"White","year":"1909","journal-title":"J. Pathol. Bacterial."},{"issue":"13","key":"10.1016\/j.intimp.2022.109074_b0640","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0645","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)65160-7","article-title":"Estrogen receptor expression in prostate cancer and premalignant prostatic lesions","volume":"155","author":"Bonkhoff","year":"1999","journal-title":"Am. J. pathol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0650","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.steroids.2012.07.002","article-title":"Current concepts and significance of estrogen receptor \u03b2 in prostate cancer","volume":"77","author":"Hartman","year":"2012","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6383","article-title":"The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer","volume":"5","author":"Chakravarty","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0660","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1432-0436.2008.00291.x","article-title":"Estrogen-regulated development and differentiation of the prostate","volume":"76","author":"McPherson","year":"2008","journal-title":"Differentiation"},{"issue":"25","key":"10.1016\/j.intimp.2022.109074_b0665","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0403041101","article-title":"Estrogen receptor \u03b2 regulates epithelial cellular differentiation in the mouse ventral prostate","volume":"101","author":"Imamov","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/pcan.2014.43","article-title":"Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy","volume":"18","author":"Roehrborn","year":"2015","journal-title":"Prostate Cancer and Prostatic Dis."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0675","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1210\/en.2011-1298","article-title":"The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors","volume":"152","author":"Nelson","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-017-0422-x","article-title":"The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ER\u03b2 in prostate cancer cells","volume":"17","author":"Raza","year":"2017","journal-title":"Cancer cell international"},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0685","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1074\/jbc.M208658200","article-title":"Inhibition of cdk2 activating phosphorylation by mevastatin","volume":"278","author":"Ukomadu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0690","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/153537020422900701","article-title":"Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention","volume":"229","author":"Mo","year":"2004","journal-title":"Exp. Biol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0695","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/1055-9965.EPI-14-1329","article-title":"Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies","volume":"24","author":"YuPeng","year":"2015","journal-title":"Cancer Epidemiol. Prevention Biomarkers"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijc.24536","article-title":"Incidence of cancer and statin usage\u2014record linkage study","volume":"126","author":"Haukka","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0705","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1541-7786.MCR-19-0974","article-title":"27-hydroxycholesterol impairs plasma membrane lipid raft signaling as evidenced by inhibition of IL6\u2013JAK\u2013STAT3 signaling in prostate cancer cells","volume":"18","author":"Dambal","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.intimp.2022.109074_b0710","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fonc.2019.00048","article-title":"Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication","volume":"9","author":"Loh","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0715","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.13","article-title":"Role of STAT3 pathway in genitourinary tumors","volume":"1","author":"Santoni","year":"2015","journal-title":"Future Sci. OA"},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0720","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2353\/ajpath.2008.071054","article-title":"Stat3 promotes metastatic progression of prostate cancer","volume":"172","author":"Abdulghani","year":"2008","journal-title":"Am. J. pathol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0725","doi-asserted-by":"crossref","first-page":"254-IN12","DOI":"10.1593\/neo.101388","article-title":"Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice","volume":"13","author":"Blando","year":"2011","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b0730","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1016\/S0021-9258(20)89517-9","article-title":"Characterization of human sterol 27-hydroxylase. a mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis","volume":"266","author":"Cali","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2022.109074_b0735","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.chemphyslip.2017.05.012","article-title":"27-hydroxycholesterol: a novel player in molecular carcinogenesis of breast and prostate cancer","volume":"207","author":"Marwarha","year":"2017","journal-title":"Chem. Phys. Lipids"},{"issue":"13","key":"10.1016\/j.intimp.2022.109074_b0740","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/pros.20630","article-title":"Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma","volume":"67","author":"Olsson","year":"2007","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b0745","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a116119","article-title":"Dietary cholesterol and incidence of lung cancer: the western electric study","volume":"134","author":"Shekelle","year":"1991","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-5002(01)00281-1","article-title":"Diet and adenocarcinoma of the lung: a case\u2013control study in Uruguay","volume":"35","author":"De Stefani","year":"2002","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0755","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2015.01.035","article-title":"Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma","volume":"457","author":"Wu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109074_b0760","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ebiom.2017.04.017","article-title":"Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy","volume":"19","author":"Yang","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0705-9","article-title":"Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas","volume":"16","author":"Wang","year":"2017","journal-title":"Molecular cancer"},{"issue":"9","key":"10.1016\/j.intimp.2022.109074_b0770","doi-asserted-by":"crossref","first-page":"e2372","DOI":"10.1038\/cddis.2016.281","article-title":"4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1\u03b1 and Caveolin-1","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0775","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2017.02.003","article-title":"25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells","volume":"484","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109074_b0780","first-page":"1","article-title":"27-hydroxycholesterol linked high cholesterol diet to lung adenocarcinoma metastasis","author":"Li","year":"2022","journal-title":"Oncogene"},{"issue":"43","key":"10.1016\/j.intimp.2022.109074_b0785","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1038\/onc.2013.440","article-title":"De Las Rivas, a gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer","volume":"33","author":"Luis-Ravelo","year":"2014","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.intimp.2022.109074_b0790","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/1389450117666161226121650","article-title":"Bone: a fertile soil for cancer metastasis","volume":"18","author":"Coughlin","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0795","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0800","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2012.12.021","article-title":"27-Hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages","volume":"430","author":"Kim","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-13-63","article-title":"25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells","volume":"13","author":"Koarai","year":"2012","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0810","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00223-017-0237-8","article-title":"Tumor necrosis factor alpha overexpression induces mainly osteoclastogenesis at the vertebral site","volume":"100","author":"Courbon","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"23","key":"10.1016\/j.intimp.2022.109074_b0815","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-\u03baB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2022.109074_b0820","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1002\/jcp.27883","article-title":"27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0825","first-page":"61","article-title":"Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort","volume":"21","author":"Mondul","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.intimp.2022.109074_b0830","doi-asserted-by":"crossref","unstructured":"C. Garbe, K. Peris, A. Hauschild, P. Saiag, M. Middleton, L. Bastholt, J.-J. Grob, J. Malvehy, J. Newton-Bishop, A.J. Stratigos, Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline\u2013Update 2016, European journal of cancer 63 (2016) 201-217.","DOI":"10.1016\/j.ejca.2016.05.005"},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0835","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bjc.2016.37","article-title":"From obesity to diabetes and cancer: epidemiological links and role of therapies","volume":"114","author":"Garc\u00eda-Jim\u00e9nez","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0840","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/jcb.26498","article-title":"Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha","volume":"119","author":"Tian","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0845","doi-asserted-by":"crossref","first-page":"e0134396","DOI":"10.1371\/journal.pone.0134396","article-title":"Estrogen receptor \u03b2 agonists differentially affect the growth of human melanoma cell lines","volume":"10","author":"Marzagalli","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0850","first-page":"123","article-title":"Expression of estrogen receptors in melanoma and sentinel lymph nodes; a \u201cfemale\u201d clinical entity or a possible treatment modality","volume":"36","author":"Spyropoulos","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.intimp.2022.109074_b0855","doi-asserted-by":"crossref","unstructured":"F. Zhong, T. Chen, J. Liu, Y. Wang, M. Yao, B. Li, DHCR24 Promotes Melanoma Stem-Like Cells Formation and Mediates Vemurafenib Resistance by Accumulating 27-Hydroxycholesterol, (2021).","DOI":"10.21203\/rs.3.rs-1148681\/v1"},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b0860","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ecl.2018.02.003","article-title":"Adrenocortical carcinoma with hypercortisolism","volume":"47","author":"Puglisi","year":"2018","journal-title":"Endocrinol. Metabolism Clinics"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0865","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cells9040885","article-title":"Involvement of 27-hydroxycholesterol in mitotane action on adrenocortical carcinoma","volume":"9","author":"Germano","year":"2020","journal-title":"Cells"},{"issue":"9927","key":"10.1016\/j.intimp.2022.109074_b0870","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"9719","key":"10.1016\/j.intimp.2022.109074_b0875","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2022.109074_b0880","article-title":"Role of microbiota-derived short-chain fatty acids in cancer development and prevention","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"29","key":"10.1016\/j.intimp.2022.109074_b0885","doi-asserted-by":"crossref","first-page":"46509","DOI":"10.18632\/oncotarget.10224","article-title":"Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer","volume":"7","author":"Swan","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0890","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/1940-6207.CAPR-20-0414","article-title":"Circulating 27-hydroxycholesterol and risk of colorectal adenomas and serrated polyps","volume":"14","author":"Passarelli","year":"2021","journal-title":"Cancer Prevention Research"},{"issue":"8","key":"10.1016\/j.intimp.2022.109074_b0895","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b0900","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.intimp.2022.109074_b0905","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-12-4051","article-title":"Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-\u03b2","volume":"73","author":"Rudolph","year":"2013","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b0910","first-page":"779","article-title":"Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the minnesota cancer prevention research unit case-control study","volume":"5","author":"Potter","year":"1996","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"issue":"9","key":"10.1016\/j.intimp.2022.109074_b0915","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-128-9-199805010-00001","article-title":"Postmenopausal hormone use and risk for colorectal cancer and adenoma","volume":"128","author":"Grodstein","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"23","key":"10.1016\/j.intimp.2022.109074_b0920","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/jnci\/93.23.1799","article-title":"Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial","volume":"93","author":"Woodson","year":"2001","journal-title":"J. Natl Cancer Inst."},{"issue":"14","key":"10.1016\/j.intimp.2022.109074_b0925","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnci\/83.14.1013","article-title":"Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer","volume":"83","author":"Andersson","year":"1991","journal-title":"JNCI: J. National Cancer Institute"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-0977-8","article-title":"Changes in lipids composition and metabolism in colorectal cancer: a review","volume":"18","author":"Pakiet","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0935","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0940","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0945","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0950","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc3912","article-title":"Targeting liver X receptors in cancer therapeutics","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2022.109074_b0955","article-title":"The Role of the cholestrol metabolite, 27-hydroxycholestrol, in colon cancer cells","author":"Warns","year":"2018","journal-title":"The University of North Dakota"},{"key":"10.1016\/j.intimp.2022.109074_b0960","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mam.2016.02.004","article-title":"Oxysterols and mechanisms of survival signaling","volume":"49","author":"Vurusaner","year":"2016","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.intimp.2022.109074_b0965","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2019.03.020","article-title":"Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration","volume":"136","author":"Rossin","year":"2019","journal-title":"Free Rad. Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b0970","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbrc.2018.09.058","article-title":"Upregulation of 24 (R\/S), 25-epoxycholesterol and 27-hydroxycholesterol suppresses the proliferation and migration of gastric cancer cells","volume":"504","author":"Guo","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109074_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112352","article-title":"Dual role of microbiota-derived short-chain fatty acids on host and pathogen","volume":"145","author":"Mirzaei","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b0980","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The role of oxysterols in human cancer","volume":"28","author":"Kloudova","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.109074_b0985","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mrfmmm.2011.10.009","article-title":"Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes","volume":"731","author":"Jusakul","year":"2012","journal-title":"Mutation Res.\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b0990","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jmcb\/mjt039","article-title":"A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth","volume":"5","author":"Lu","year":"2013","journal-title":"J. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-1-1","article-title":"MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming","volume":"13","author":"Liu","year":"2020","journal-title":"J. hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-63758-2","article-title":"Urinary and serum oxysterols in children: developmental pattern and potential biomarker for pediatric liver disease","volume":"10","author":"Takaki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.109074_b1005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.12.007","article-title":"Nrf2 antioxidant defense is involved in survival signaling elicited by 27-hydroxycholesterol in human promonocytic cells","volume":"91","author":"Vurusaner","year":"2016","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.intimp.2022.109074_b1010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.freeradbiomed.2014.07.026","article-title":"Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK\/Akt phosphorylation","volume":"77","author":"Vurusaner","year":"2014","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.intimp.2022.109074_b1015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fendo.2018.00470","article-title":"Estrogen receptor beta-mediated modulation of lung cancer cell proliferation by 27-hydroxycholesterol","volume":"9","author":"Hiramitsu","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2022.109074_b1020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxlet.2016.11.006","article-title":"The ROS-mediated activation of STAT-3\/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells","volume":"264","author":"Zhu","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.intimp.2022.109074_b1025","first-page":"1","article-title":"27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming","author":"Jin","year":"2021","journal-title":"Cell Biol. Toxicol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109074_b1030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/sj.ijo.0802714","article-title":"Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project","volume":"28","author":"Gostynski","year":"2004","journal-title":"Int. j. obesity"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2009.09.027","article-title":"Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers","volume":"116","author":"Li","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2008.06.007","article-title":"Impact of statin therapy on survival in epithelial ovarian cancer","volume":"111","author":"Elmore","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b1045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2013.05.025","article-title":"The effect of statins on risk and survival of gynecological malignancies","volume":"130","author":"Lavie","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109074_b1050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ijc.31758","article-title":"Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study","volume":"144","author":"Akinwunmi","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2016.435","article-title":"Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)","volume":"116","author":"Lindemann","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b1060","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/ERC-18-0572","article-title":"Host CYP27A1 expression is essential for ovarian cancer progression","volume":"26","author":"He","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"35","key":"10.1016\/j.intimp.2022.109074_b1065","first-page":"4225","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment, journal of clinical oncology : official journal of the american society of","volume":"34","author":"Onstad","year":"2016","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b1070","first-page":"232","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Human reproduction update"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1075","first-page":"261","volume":"24","author":"Trabert","year":"2015","journal-title":"Oncology"},{"issue":"13","key":"10.1016\/j.intimp.2022.109074_b1080","doi-asserted-by":"crossref","first-page":"16996","DOI":"10.18632\/oncotarget.7913","article-title":"Cholesterol consumption and risk of endometrial cancer: a systematic review and dose-response meta-analysis of observational studies","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/carcin\/bgp029","article-title":"The oxysterol receptor LXR inhibits proliferation of human breast cancer cells","volume":"30","author":"Vedin","year":"2009","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b1090","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1194\/jlr.M007989","article-title":"Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity","volume":"51","author":"Kim","year":"2010","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/ERC-17-0449","article-title":"The impact of 27-hydroxycholesterol on endometrial cancer proliferation","volume":"25","author":"Gibson","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-005-2993-4","article-title":"Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer","volume":"268","author":"Michalaki","year":"2005","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2022.109074_b1105","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.24668","article-title":"Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts","volume":"125","author":"Iso","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b1110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea","volume":"29","author":"Kitahara","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2265.2012.04506.x","article-title":"Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer","volume":"78","author":"Kim","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b1120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/thy.2013.0566","article-title":"Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case\u2013control studies","volume":"24","author":"Xu","year":"2014","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46727-2","article-title":"Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness","volume":"9","author":"Revilla","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.109074_b1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112760","article-title":"Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis","volume":"148","author":"Bouzari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2022.109074_b1135","article-title":"Role of microbiota-derived short-chain fatty acids in nervous system disorders","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1140","first-page":"3623","article-title":"The oncogenic roles of 27-hydroxycholesterol in glioblastoma","volume":"18","author":"Liu","year":"2019","journal-title":"Oncology Lett."},{"key":"10.1016\/j.intimp.2022.109074_b1145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1194\/jlr.M600529-JLR200","article-title":"A novel route for the elimination of brain oxysterols: elimination of 27-hydroxycholesterol via conversion to 7alpha-hydroxy-3-oxo-4-cholestenoic acid","volume":"48","author":"Meaney","year":"2007","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1096\/fj.07-9944com","article-title":"ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.intimp.2022.109074_b1160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2009.08.003","article-title":"Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling","volume":"164","author":"Gilardi","year":"2009","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.intimp.2022.109074_b1165","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1210\/endo.142.7.8244","article-title":"Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression","volume":"142","author":"Javitt","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/03602532.2013.835609","article-title":"SULT2B1: unique properties and characteristics of a hydroxysteroid sulfotransferase family","volume":"45","author":"Falany","year":"2013","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1175","first-page":"203","volume":"18","author":"Hong","year":"2019","journal-title":"Hydroxysteroid sulfotransferase 2B1 affects gastric epithelial function and carcinogenesis induced by a carcinogenic agent"},{"issue":"50","key":"10.1016\/j.intimp.2022.109074_b1180","doi-asserted-by":"crossref","first-page":"39685","DOI":"10.1074\/jbc.M007653200","article-title":"Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia reversal by cholic acid feeding,","volume":"275","author":"Repa","year":"2000","journal-title":"J. biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1194\/jlr.R031534","article-title":"Cytochrome P450-mediated metabolism of vitamin D","volume":"55","author":"Jones","year":"2014","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b1190","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2000.3050","article-title":"Metabolism of vitamin D(3) by human CYP27A1","volume":"273","author":"Sawada","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2022.109074_b1195","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10549-017-4562-4","article-title":"Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial","volume":"167","author":"Going","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/cells11010094","article-title":"A role for ER-beta in the effects of low-density lipoprotein cholesterol and 27-hydroxycholesterol on breast cancer progression: involvement of the IGF signalling pathway?","volume":"11","author":"Mashat","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.intimp.2022.109074_b1205","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJMcibr1315176","article-title":"On estrogen, cholesterol metabolism, and breast cancer","volume":"370","author":"Warner","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-021-00296-1","article-title":"The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection","volume":"27","author":"Mirzaei","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2022.109074_b1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577640","article-title":"The pathogenic, therapeutic and diagnostic role of exosomal microrna in the autoimmune diseases","volume":"358","author":"Mirzaei","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109074_b1220","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1373\/clinchem.2015.240028","article-title":"The role of exosomes in breast cancer","volume":"61","author":"Lowry","year":"2015","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2022.109074_b1225","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","article-title":"Exosomes: extracellular organelles important in intercellular communication","volume":"73","author":"Mathivanan","year":"2010","journal-title":"J. Proteomics"},{"issue":"39","key":"10.1016\/j.intimp.2022.109074_b1230","doi-asserted-by":"crossref","first-page":"66033","DOI":"10.18632\/oncotarget.19789","article-title":"7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.20892\/j.issn.2095-3941.2019.0262","article-title":"27-Hydroxycholesterol-induced EndMT acts via STAT3 signaling to promote breast cancer cell migration by altering the tumor microenvironment","volume":"17","author":"Jiao","year":"2020","journal-title":"Cancer biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109074_b1240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10565-020-09564-y","article-title":"The 14-3-3\u03b7\/GSK-3\u03b2\/\u03b2-catenin complex regulates EndMT induced by 27-hydroxycholesterol in HUVECs and promotes the migration of breast cancer cells","volume":"37","author":"Zhen","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2022.109074_b1245","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.783823","article-title":"27-hydroxycholesterol, the estrogen receptor modulator, alters DNA methylation in breast cancer","volume":"13","author":"Vini","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109074_b1250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-015-2551-7","article-title":"The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells","volume":"410","author":"Raza","year":"2015","journal-title":"Mol. Cell. Biochem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:58:39Z","timestamp":1761587919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":250,"alternative-id":["S1567576922005586"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109074","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of 27-hydroxycholesterol in cancer development and progression: An update","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109074"}}